Browse > Article

A Retrospective Study of Chronic Pulmonary Disease Patients Treated with Chungsangboha-tang : IgE, eosinophil, PFT  

Baek, Hyun-jung (Division of Allergy, Immune & Respiratory System, Graduate School, Kyung-Hee University)
Bhang, Yeon-hee (Division of Allergy, Immune & Respiratory System, Graduate School, Kyung-Hee University)
Kim, Jae-hyo (Division of Allergy, Immune & Respiratory System, Graduate School, Kyung-Hee University)
Kim, Sang-jin (Division of Allergy, Immune & Respiratory System, Graduate School, Kyung-Hee University)
Kim, Kwan-il (Division of Allergy, Immune & Respiratory System, Graduate School, Kyung-Hee University)
Lee, Beom-joon (Division of Allergy, Immune & Respiratory System, Graduate School, Kyung-Hee University)
Jung, Hee-jae (Division of Allergy, Immune & Respiratory System, Graduate School, Kyung-Hee University)
Jung, Sung-ki (Division of Allergy, Immune & Respiratory System, Graduate School, Kyung-Hee University)
Publication Information
The Journal of Internal Korean Medicine / v.37, no.3, 2016 , pp. 484-494 More about this Journal
Abstract
Objective: This study was designed to analyze the treatment effects of Chungsangboha-tang through retrospective chart reviews.Methods: Fifty-one outpatients who had visited the Allergy, Immune & Respiratory System Division at the Kyung Hee Korean Medicine Hospital and who had taken Chungsangboha-tang from February 1, 2006, to February 1, 2016, had their basic medical records and examinationsretrospectively reviewed with respect to IgE, eosinophil, AST, and ALT. The PFT results of 11 patients were also investigated with respect to FEV1, FVC, and FEV1/FVC.Results: The percentage of males and females was 49.02% and 50.98%, respectively. The past histories of patients included asthma (66.67%), unspecified cough (21.57%), COPD (9.80%), allergic rhinitis (7.84%), and others. The subjective symptoms included cough (82.35%), sputum (39.22%), dyspnea (37.25%), and others. The most numerous pattern identification was wheezing dyspnea. IgE was significantly reduced, and eosinophil had a reduced tendency after 116.76±160.40 days of taking Chungsangboha-tang. PFT results also significantly increased after 213.09±266.62 days, while AST and ALT results showed a reduced tendency. In the asthmatic group, IgE also showed a reduced tendency. In particular, IgE was significantly reduced in patient groups taking medicine for more than 12 weeks.Conclusions: The conditions of patients with chronic pulmonary disease such as asthma and COPD significantly improved with Chungsangboha-tang after more than 12 weeks.
Keywords
Chungsangboha-tang; asthma; COPD; IgE; eosinophil; PFT; cough;
Citations & Related Records
Times Cited By KSCI : 10  (Citation Analysis)
연도 인용수 순위
1 National University of Dept. of Internal Medicine Pulmonary System. Internal Medicine Pulmonary System. Seoul: Nado; 2011, p. 96, 273, 510-2, 771.
2 Jeong SY, Lee JS, Choi JY, Lee KY, Jung HJ, Lee HK. Clinical effects of AF-365 for maintenance therapy in chronic stages of asthmas. Korean J Orienta Int Med 2005;26(1):1-11.
3 Jung SK, Hwang WS, Ju CY, Lee JS, Cho IH, Jung HJ. Clinical Effects of Chuongsangboha-tang in Asthmatic Patients. J Korean Oriental Med 2002;23(4):151-60.
4 Bang JH, Jung HJ, Jung SK. A Clinical Observation of Chungsangboha-tang's Effects on Asthmatic Patients. Korean J Orienta Int Med 2011;32(1): 10-25.
5 Heo TS, Ko EJ, Jung HJ, Lee HK, Bae HS, Jung SK. Studying of the Effects of Gamichungsangboha-tang water-extract and ethanol-extract on IFN-γ, IL-4, T-bet, GATA-3, c-maf in Asthma Model. Korean J Orienta Int Med 2006;27(1):40-54.
6 Lee KH, Kim HY, Jung HJ, Lee HK. Effect of Chungsangboha-tang on LPS induced Anti-inflammatory in THP-1 cells. Korean J Orienta Int Med 2008;29(1):12-24.
7 Jeongdam Editorial Department. Step To Internal Medicine Immunology.Allergy 7. Seoul: Jeongdam; 2013, p. 62.
8 NEO Handbook Editorial Department. NEO Intern Handbook. Seoul: Gunja; 2011, p. 129, 130, 170.
9 Won HR. The role of serum eosinophil cationic protein as a marker of chronic inflammation in paranasal sinus. The graduate school Chung-ang University 2011.
10 National Teacher Training Center for Health Personnel. Family Medicine. Seoul: Seoul National University Editorial Department; 1998, p. 1308.
11 The Korean Academy of Tuberculosis and Respiratory Disease Asthma Treatment Guideline Revision Committee. Asthma Treatment Guideline 2014 Revision. The Korean Academy of Tuberculosis and Respiratory Disease 2014;11, 12, 19.
12 The Korean Academy of Tuberculosis and Respiratory Disease COPD Treatment Guideline Revision Committee. COPD Treatment Guideline 2014 Revision. The Korean Academy of Tuberculosis and Respiratory Disease 2014;3, 4.
13 Jung SK, Lee HK. A Clinical Observation of Gamichungsangboha-tang on Asthma. Kyung-Hee hak 1986;2(4):97-102.
14 American Thoracic Society. Guidelines for methacholine and exercise challenge testing-1999. Am J Respir Crit Care Med 2000;161:309-29.   DOI
15 An JE, Yu LY, Lee JH. Medical․Public Health Statistical Analysis. Seoul: KoRyeo Information Industry; 2000, p. 261-423.
16 Gong TX. Shoushibaoyuan. Beijing: Renminweishengchubanshe: 1994, p. 169-70.
17 Lee HK, Jung SK, Jung HJ, Kwan H. A Study on the Effects of Chungsangboha-tang on Allergic Asthma in Respiratory Pattern and Change of Eosinophil Infiltration in Tracheal Mucosa. Kyung-Hee Korean Medicine University Collection 1999;22(1):203-15.
18 Park YS, Bae HS, Hong MC, Shin MK. Effects of Chungsangboha-tang on Activity of Naive CD4+ T cell. Korean J Oriental Physiology & Pathology 2002;16(4):801-9.
19 Jeong SY, SH Lee, JH Hwang, Lee KY, Kim JJ, Jung HJ, et al. The inhibitory effects of hot water and ethanol extract of Gamichungsangbohatang on cytokines related to ashtma. Korean J Orienta Int Med 2006;27(2):521-32.
20 Jung SK. An Experimental Studies on the Effects of Gamichungsangbohatang on Asthma. Journal of Korean Medicine 1991;12(1):118-38
21 Hwang WS, Lee JS, Ju CY, Jung HJ, Lee HK, Jung SK. The Clinical Study on 1 Case of Hyperthyroid patient Treated with Yukmijihwangtang. Korean Journal of Oriental Adult Disease 2002; 8(1):53-63.
22 Hwang WS, Choi JY, Lee JS, Ju CY, Jung HJ, Lee HK, et al. The Steroid Sparing Effects of Cheongsangboha-tang in Asthmatic Patients. Korean J Orienta Int Med 2003;24(1) :1-10.
23 Park IW, Hue SH, Kim SH, Sung YU, Koh HG, Kang YC, et al. the effect of inhaied disodium cromoglycate on the peripheral blood eosinophil count and serum IgE level in stable brochial asthmatics. Allergy 1995;15(2):230-4.
24 Choi JY, Lee JS, Jeong SY, Lee KY, Lee KK, Jung HJ, et al. An Analysis of Therapeutic Effects of Gamichuongsangboha-tang in 30 Asthmatics Based on Criteria for Defiency-Excess Differentiating Syndromes of Asthma. Korean J Orienta Int Med 2004;25(3):379-87.
25 Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002;121:1434-40.   DOI
26 Min YG. The pathophysiology, diagnosis and treatment of allergic rhinitis. Allergy Asthma Immunol Res 2010;2(2):65-76.   DOI
27 Yoo KH, Kim YS, Sheen SS, Park JH, Hwang YI, Kim SH, et al. Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean. National Health and Nutrition Examination Survey, 2008. Respirology(Carlton, Vic.) 2011;16:659-65.
28 Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:442.   DOI
29 Statistics Korea. The Statistic Results of Death Cause 2010. Daejeon: Statistics Korea; 2011.
30 Roh GS1, Seo SW, Yeo S, Lee JM, Choi JW, Kim E, el al. Efficacy of traditional Korean Medicine, Chung-Sang-Bo-Ha-Tang, in a murine model of chronic asthma. Int Immunopharmacol 2005;5(2):427-36.   DOI
31 Chung HL. Clinical significance of serum IgE. Korean Journal of Pediatrics 2007;50(5):416-21.   DOI